This website uses cookies to enhance the user experience.
P

PHARMAMENTOR AS916 006 551

Counseling
Limited company
Frydentoppveien 16 4844 ARENDAL, Norge

PHARMAMENTOR AS

Keywords

consultingguidanceassistancemanagement issuesstrategicorganizationalreorganizationbusiness procedureschange managementcost reductionpersonnelremunerationpension strategiesproduction planningcontrol planninglobbyingaccounting procedurescost accountingbudget control proceduresrationalizationcontrolmanagement information

Organization

CEO
Chairman of the board
Years since formation
10 years
since Sep 30, 2015
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
300
1 share class
Total number of shareholders
1
person

Financials

Annual total result 2023
-358,122
NOK
Total equity 2023
446,887
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly
Board Member-

Others

NameRoleShares
E
ECIT NORMANN & ØYGARDEN AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
300
100 %

Shares owned by the PHARMAMENTOR AS

NameShare classNumber of sharesShare
I
INSULIFE AS
NO0012753625
6,085,050
8.78 %
S
SUNSENSE AS
Ordinary shares
17,423
2.27 %
A
ARCTIC BIOSCIENCE AS
NO0010859580
63,500
0.25 %
P
PCI BIOTECH HOLDING ASA
NO0010405640
13,300
0.04 %
I
INANOD AS
Ordinary shares
1,000
0.03 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
769
< 0.01 %
A
AIRTHINGS ASA
NO0010895568
2,500
< 0.01 %
C
CIRCIO HOLDING ASA
NO0013033795
366
< 0.01 %
E
EXACT THERAPEUTICS AS
NO0010852213
1,100
< 0.01 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
769,245
Annual Total Result
-358,122
31,824
-633,968
Total assets
523,375
851,594
967,896
Total liabilities
76,488
46,585
194,711
Total equity
446,887
805,009
773,185

P&L

Year202320222021
Total operating income
0
0
769,245
Total operating costs
110,539
123,125
847,311
Operating result
-110,539
-123,125
-78,067
Financial income/costs
-247,583
154,949
-557,882
Profit before tax
-358,122
31,824
-635,948
Total tax & extraordinary income/cost
0
0
-1,980
Annual Total Result
-358,122
31,824
-633,968

Balance overview

Year202320222021
Total fixed assets
0
0
3,000
Total current assets
523,375
851,594
964,896
Total assets
523,375
851,594
967,896
Short term debt
76,488
863
80,421
Long term debt
0
45,722
114,290
Total liabilities
76,488
46,585
194,711
Contributed capital
25,000
25,000
25,000
Retained earnings
421,887
780,009
748,185
Total equity
446,887
805,009
773,185
Total equity and liabilities
523,375
851,594
967,896

Classification

Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
70
Activity
Activities of head offices; management consultancy activities
70.2
Main industrial group
Management consultancy activities
70.22
Industrial group
Business and other management consultancy activities
70.220
Industrial group
Business and other management consultancy activities